A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Matt Kaeberlein, the CEO of Optispan, shared his longevity habits. Matt Kaeberlein Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels…
Perspective Analysis
Comparing sources…
How outlets covered this
Left-leaning
No articles
Center
Right-leaning
No articles
Coverage Timeline
Read at source (2 outlets)
A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Read full article →A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Matt Kaeberlein, the CEO of Optispan, shared his longevity habits. Matt Kaeberlein Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels tested in his 50s and gradually began testosterone replacement therapy (TRT). He said everyone should know 4 things before starting TRT. In 2020, longevity researcher Matt Kaeberlein started wondering if he had low testosterone levels. Then, in his early 50s, Kaeberlein had all the classic symptoms...
Read full article →Related Stories
Alleged negligence: MDCN suspends three doctors over Chimamanda son’s death
8m ago
Man collapses, dies while jogging in Rivers
8m ago
Specific diet reduces the risk of up to five types of cancer, but there is also bad news
53m ago
Your week without sweets surprised you – Greta shared what changes she experienced
1h ago